Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
about
Assessment of air pockets in high-dose-rate vaginal cuff brachytherapy using cylindrical applicators.Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning.Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planningRisk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma.A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical stagingOveruse of external beam radiotherapy for stage I endometrial cancerCurrent treatment strategies for endometrial cancer.No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer.American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.Treatment planning methodology for the Miami Multichannel Applicator following the American Brachytherapy Society recently published guidelines: the Lahey Clinic experience.Bladder and rectum dose estimations on digitized radiographs for vaginal brachytherapy after hysterectomy.Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial Cancer.
P2860
Q34355178-1B6BA884-2407-4EBF-92FE-022BFC426EE3Q34990082-238C6A6A-D3E8-4567-A125-5805246E4381Q35939761-D89B74C1-29CE-4EF1-AA9C-973E941C13E2Q36313283-FA237F2F-197B-4D8C-9D8B-991AC63BB15AQ36544016-317D3F87-70D2-4CDE-BA3A-C6E08C19EFD1Q36886237-CB07F9E7-09A3-49B1-A008-FAA6F09FCFB0Q37038694-05F07B2A-990E-42C6-97D3-9DDC48C59C55Q37202781-4FBDD814-4DEE-4146-8FEA-CEB6DE8CE4D2Q37774355-EB529805-EDF6-4BE2-9877-8FD44A3AF5FCQ38853338-0C417348-01AD-42BE-A5E3-8EAAB213681AQ43601074-EAEB4BAC-491F-406B-BC8C-8583159425AFQ48528910-BA452CAC-FFDE-45A6-824A-80027A224EB6Q51480749-1AA217C4-2AFB-4974-A232-3F266C70AA6EQ54942423-F2B7C455-E723-4947-A145-44E8E4BCB6A7Q55082033-BD1059B5-B83F-42C0-9D0A-7D38ED49A0DC
P2860
Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@ast
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@en
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@nl
type
label
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@ast
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@en
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@nl
prefLabel
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@ast
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@en
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@nl
P2093
P1476
Adjuvant high dose rate vagina ...... and II endometrial carcinoma.
@en
P2093
Charles W Drescher
Mary Atwood
Michael R Smith
Neil S Horowitz
Timothy P Mate
William A Peters
P304
P356
10.1016/S0029-7844(01)01672-6
P407
P577
2002-02-01T00:00:00Z